Best Biopharma Outsourcing Companies in Florida, United States
The 111 best Biopharma Outsourcing companies in Florida, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Zenas BioPharma.
Our analysis of 50 Biopharma Outsourcing companies
$6.3b in tracked funding; 77% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Biopharma Outsourcing companies in Florida
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Zenas BioPharma Provider of clinical development services for autoimmune and rare diseases | $318M | 25 mo ago | Public | — | 2020 | DrupalPHPAmazon Web Services+27 | 33 patents Biologic antibody therapeutics for autoimmune and inflammatory diseases | — |
| 2 | Ology Bio Biologics-focused contract development and manufacturing organization (CDMO) | $80M | 94 mo ago | Acquired | — | 1999 | — | — | — |
| 3 | Aster Insights Provider of contract based oncology clinical trial services | $75M | 63 mo ago | Series C | — | 2006 | — | — | — |
| 4 | Kincell Bio Provider of clinical cell therapy development & manufacturing and consulting services 55Funding top 36%Growth top 38%Talent top 46%News bottom 48% All 6 signals ▾Fundingtop 36% Growthtop 38% Talenttop 46% Newsbottom 48% Marketbottom 44% Globalbottom 29% Funding: Raised $36.0M across 2 rounds · 2 rounds over 3 yrs (0.7/yr) Growth: Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 55/100 | $36M | 13 mo ago | Series A | Bruce Thompson CTO | 2023 | — | — | — |
| 5 | Sancilio & Company Biopharmaceutical startup guidance, development services, and strategic support for entrepreneurs | $27M | 101 mo ago | Series B | Frederick Sancilio Co-Founder | 2005 | — | 55 patents Lipid-based self‑micellizing drug delivery systems and omega‑3 fatty acid ester pharmaceuticals. | — |
| 6 | GBI Provider of contract based drug manufacturing, regulatory support, and quality assurance services 42Funding top 31%Growth top 43%Tech top 45%Talent bottom 49% All 7 signals ▾Fundingtop 31% Growthtop 43% Techtop 45% Talentbottom 49% Globalbottom 32% Marketbottom 27% Newsbottom 22% Funding: Raised $25.7M across 4 rounds · 4 rounds over 7 yrs (0.6/yr) Growth: Headcount 61 → 62 (+2%) across vintages · Web rank 50,000,000 → 10,000,000 YoY rank vs industry peers · Fliar Intelligence Index 42/100 | $26M | 6 mo ago | Early Stage | Darrin Schellin Chief Executive Officer | 1992 | WordPressApple iCloud MailMicrosoft 365+20 | — | — |
| 7 | Boca Biolistics CRO focused on providing clinical development services for oncology drugs | $25M | 40 mo ago | Series B | — | 2005 | — | — | — |
| 8 | CoreRx CDMO with a focus on early phase drug product development | $15M | 87 mo ago | Acquired | — | 2006 | — | — | — |
| 9 | Miramar Lab Provider of pharmaceuticals formulations manufacturing and packaging services | $12M | 112 mo ago | Series A | Victor Ramirez CEO | 2003 | — | — | — |
| 10 | American Injectables CDMO focused on manufacturing of sterile injectable pharmaceuticals | $10M | 68 mo ago | Series A | Travis Allen Founder & CEO | 2020 | HubSpot CMS Hubcore-jsFlickity+12 | — | — |
| 11 | CMOCRO Provider of pharmaceutical research, development & manufacturing services | $6M | 62 mo ago | Funding Raised | Chris Adam News Author | 2010 | PHPBootstrapjQuery UI+8 | — | — |
| 12 | ASP Isotopes Provider of supply chain solution services | $5M | 32 mo ago | Public | Paul Mann Founder | 2021 | WordPressMySQLPHP+23 | — | 2 partnerships · 1 expansion |
| 13 | Alchem Laboratories Alchem Laboratories specializes in custom organic synthesis, cGMP production, and analytical services. | $2M | 13 mo ago | Funding Raised | James Talton President and CEO | 1997 | Cart FunctionalitySquarespace CommerceSquarespace+14 | 16 patents Patents concentrated in chemistry & materials | — |
| 14 | Protean BioDiagnostics Developer of biodiagnostic tests and biopharma research services | $2M | 13 mo ago | Series A | Anthony Magliocco Founder and President | 2017 | Cart FunctionalitySquarespace CommerceSquarespace+23 | — | — |
| 15 | Abriusa Operator of a clinical research network conducting Phase I-IV trials | $225K | 81 mo ago | Funding Raised | — | 2007 | — | — | — |
Top 12 Biopharma Outsourcing companies in Florida
#1
Early Stage · Plantation, Florida · founded 1992 · 62 employees$25.7Mraised▾
Provider of contract based drug manufacturing, regulatory support, and quality assurance services
- Dec 2025Unattributed$2M
- Nov 2024Unattributed$3M
- Oct 2023Unattributed$5M
- Apr 2019PE$20.7M
#2
Series A · Gainesville, Florida · founded 2023$36Mraised▾
Provider of clinical cell therapy development & manufacturing and consulting services
- May 2025Series A$22M
- Jul 2023Series A$36M
#3
Public · Fort Myers, Florida · founded 2020 · 49 employees$318.1Mraised▾
Provider of clinical development services for autoimmune and rare diseases
- May 2024Series C$200.1M
- Nov 2022Series B$118M
- Mar 2021Series A—
#4
Funding Raised · Alachua, Florida · founded 1997$1.9Mraised▾
Custom research organization providing synthesis, manufacturing, and analytical services. They are a pharmaceutical manufacturing company specializing in custom organic synthesis and cGMP manufacturing. They offer a range of capabilities including synthesis, discovery, manufacturing, analytical, and clinical services. They serve as a partner for pharmaceutical companies, offering contract services. Their expertise lies in providing custom research solutions, performing custom organic synthesis, and delivering cGMP manufacturing services. They focus on pharmaceutical manufacturing, offering services to support drug development and production.
- May 2025Grant (prize money)$955.4K
- Feb 2025Grant (prize money)$955.4K
#5
Series A · Tampa, Florida · founded 2017 · 16 employees$1.8Mraised▾
Developer of biodiagnostic tests and biopharma research services
- Apr 2025Grant (prize money)$3M
- May 2021Series A$1.4M
- Jun 2019Seed$330K
#6
Series B · Pompano Beach, Florida · founded 2005 · 22 employees$25Mraised▾
CRO focused on providing clinical development services for oncology drugs
- Feb 2023Series B$25M
#7
Series C · Tampa, Florida · founded 2006 · 115 employees$75Mraised▾
Provider of contract based oncology clinical trial services
- Mar 2021Series C—
- Sep 2017Series B$75M
#8
Acquired · Alachua, Florida · founded 1999 · 300 employees$80.5Mraised▾
Ology Bioservices (formerly Nanotherapeutics) is a biologics-focused contract development and manufacturing organization (CDMO) serving both government and commercial clients. It offers services such as process development, cell line development, cGMP manufacturing, analytical & regulatory for recombinant proteins, monoclonal antibodies, viral vaccines, and gene therapy drug products. The company has developed proprietary vaccine delivery technologies and platform expression systems. The company uses their proprietary Vero Cell vaccine manufacturing cell line acquired from Baxalta/Baxter Vaccines for the development of inactivated whole virus vaccines. It offers mammalian cell line development capabilities. The company has a BSL-3 & cGMP compliant vaccines manufacturing facility called Advanced Development and Manufacturing (ADM) facility. The company has several vaccine programs available for partnering and/or licensing such as ross river (phase III), chikungunya, pandemic and seasonal flu vaccines, yellow fever (MVA), typhoid, West Nile and norovirus.
- Aug 2018Grant (prize money)$8.4M
- Mar 2018PE—
- Mar 2015Conventional Debt$28.5M
- Sep 2014Conventional Debt$8M
#9
Public · Boca Raton, Florida · founded 2021 · 4 employees$5Mraised▾
Provider of supply chain solution services
- Oct 2023Post IPO—
- Mar 2023Post IPO$5M
#10
Series B · Riviera Beach, Florida · founded 2005$27.2Mraised▾
Biopharmaceutical startup guidance, development services, and strategic support for entrepreneurs. The company offers expert support to entrepreneurs in the early stages of pharmaceutical ventures, addressing regulatory compliance, manufacturing, quality assurance, and funding. It helps evaluate business plans and generate compelling presentations for investors. Through its global network, it provides seamless and cost-effective development processes, including manufacturing of pharmaceutical active materials, formulation, analytical development, quality control, clinical studies, and regulatory submissions. The company focuses on adding value and facilitating success in the biopharmaceutical industry. It offers services like project evaluations, planning, full development services, funding programs, licensing, exit strategy, social media, and website generation. The company provides guidance in navigating the complexities of the pharmaceutical landscape, ensuring compliance, and securing funding for innovative ventures.
- Jan 2018Series B$5M
- Feb 2016Conventional Debt—
- May 2014Series B$20M
- Feb 2012Series A$2M
#11
Acquired · Clearwater, Florida · founded 2006 · 201 employees$15Mraised▾
CoreRx is a contract pharmaceutical development organization that helps clients get into the clinic faster, providing a complete spectrum of cGMP solutions for pharmaceutical dosage form development. Their service offerings span the following: Pre-formulation, Analytical Development, Product Formulation, Clinical Manufacturing, Certified Clinical Facilities, Core Technical Services. CoreRx supports contract drug development for the following: Solid Oral (tablets, multi-layered tablets, ODT; capsules, multi-particulate drug delivery); API/Drug substance in capsules/bottles; Semi-solids (creams, ointments, lotions, gels); Liquids (oral liquids, injectables, suspensions, ophthalmics)
- Mar 2019Series A$3M
- Apr 2017Series A$5M
- Mar 2015Series A$7M
- Jun 2013Grant (prize money)$200K
#12
Funding Raised · North Miami Beach, Florida · founded 2010 · 20 employees$5.5Mraised▾
Provider of pharmaceutical research, development & manufacturing services
- Apr 2021Grant (prize money)$210K
- Jan 2020Grant (prize money)$1.9M
- Apr 2019Grant (prize money)$224.7K
- Jul 2018Grant (prize money)$225K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Biopharma Outsourcing coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology in Florida is moving
A read on the academic research around Biotechnology in Florida — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 155 papers.
Florida's University of Florida, Mayo Clinic, and USF lead moderately optimistic biotechnology research, predominantly advancing RNA interference, gene delivery, and ALS therapeutics with growing recent momentum.
- University of Florida83
- Mayo Clinic in Florida21
- University of South Florida13
- Florida College11
- Florida Agricultural and Mechanical University7
- Aptamer4
- In vivo3
- Polymerase chain reaction3
- Population2
- Xylose2
- Agriculture4
- Gene expression4
- Gene3
- Gene knockdown3
- Aptamer3
- Population3
- Food safety3
- Food processing3
- Biofilm2
- Food industry2
Common questions
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.